TRAINING
educational programmes remain relevant, practical and aligned with service needs. This collaborative model facilitates the sharing of best practice, supports national workforce and service strategies, and enables the integration of education with service delivery and transformation initiatives. By positioning itself as both a quality
assessment provider and an educational partner, UK NEQAS CPT plays a vital role in supporting the continued evolution of cellular pathology services. This collective, integrated approach ensures that education delivers meaningful impact, benefiting individuals, organisations and ultimately patient outcomes.
Why this matters now The need to build diagnostic capability has never been more urgent. Increasing demand, technological advancement, and workforce pressures are converging to create a challenging environment for diagnostic services. At the same time, diagnostics are
becoming increasingly central to personalised medicine, early detection, and patient centred care. In this context, organisations must
move beyond traditional training models and embrace integrated, workforce focused approaches to development. UK
Chantell Hodgson is Scheme Director for UK NEQAS CPT, known for her strategic leadership, service innovation, and contributions to global external quality assessment in cellular pathology. An HCPC- registered biomedical scientist and chartered scientist, she brings over 30 years of experience across diagnostics, research, and education. She is dedicated to advancing diagnostic quality, professional development, and education worldwide. Chantell serves as UK NEQAS Trustee and Vice President for Marketing and Communications, and Chair of the IBMS Cellular Pathology Advisory Commitee. She is also an international lecturer and published author and contributor to international texts and journals.
Lorren Mitchell is the Scheme Manager for UK NEQAS CPT. She is responsible for the day-to-day operations and long-term strategic management of the service. She has over 15 years’ experience in cellular pathology within a diagnostic seting with extensive involvement in the implementation of digital pathology. Lorren is a HCPC-registered biomedical scientist, a member of the IBMS, IBMS verifier and examiner.
UK NEQAS CPT’s provision of services and educational opportunities is the largest worldwide, offering a rich diversity of options – the only EQA service to develop such an expansive, unique, and accredited portfolio, commited to quality improvement, learning and development in cellular pathology diagnostics. This involves leadership, development and delivery of extended educational provision and additional services for technical and clinical staff, for worldwide quality development.
www.ukneqascpt.org/education-and-events
NEQAS CPT’s educational ecosystem offers a practical and scalable solution to this challenge – placing people at the centre of diagnostic excellence.
Conclusion: investing in people Diagnostics are only as strong as the people who deliver them. Ensuring the sustainability, quality, and consistency of diagnostic services requires a deliberate focus on workforce capability. Through its integrated educational ecosystem, UK NEQAS CPT is helping
to build that capability – supporting professionals at every stage of their careers, aligning learning with real- world practice, and strengthening the foundations of diagnostic quality. As healthcare continues to evolve, the
organisations that invest in their people will be best positioned to meet future challenges. In this regard, UK NEQAS CPT exemplifies how education, partnership, and innovation can come together to create a resilient and future ready biomedical workforce.
PPi
May 2026
WWW.PATHOLOGYINPRACTICE.COM 31
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
